Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OpT In: Thiamine for Wernicke-Korsakoff Syndrome
NCT02788552Phase 4Completed
- Sponsor
- Menzies School of Health Research
- Start
- Sep 2014
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of thiamine in Wernicke-Korsakoff syndrome (WKS), sponsored by Menzies School of Health Research. Started Sep 2014; status: completed.
02
Drugs
thiamine
03
Conditions
Wernicke-Korsakoff syndrome (WKS)
Beyond the preview
Go deeper on NCT02788552.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02788552.